Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Apr 26, 2011


Epigenomics has tapped Noel Doheny to be the new CEO of its subsidiary in Seattle. Doheny will start in his new position next month, the Berlin-based company said.

Doheny was most recently CEO of OpGen. Before that, he held positions as senior vice president for the molecular diagnostics division of Affymetrix , vice president of pre-analytical solutions at Qiagen, and president and CEO of BioStar.

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.